Home » Trials » SLCTR/2023/021 » Publications
| Publication Title | Publication Citations | ||
|---|---|---|---|
| A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy | Lafayette, R., Barbour, S., Israni, R., Wei, X., Eren, N., Floege, J., Jha, V., Kim, S.G., Maes, B., Phoon, R.K. and Singh, H., 2024. A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy. Kidney international, 105(6), pp.1306-1315. |
